EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.

Europe’s EMA recommended approving Moderna’s combined COVID-flu shot for ages 50+, with a final marketing decision pending from the European Commission.

If the recommendation is accepted by the European Commission, Moderna's mCombriax vaccine will be available for adults 50 and older throughout the European Union.

MRNA, received a positive opinion from the European Medicines Agency’s CHMP for mCOMBRIAX, a combined COVID 19 and flu vaccine. The committee recommended mCOMBRIAX for marketing authorization in the ...

NEW BRUNSWICK, N.J. -- Booster doses of Johnson & Johnson's one-shot coronavirus vaccine generated a big spike in antibodies, the frontline immune system defenses against infection, the company ...

The Centers for Disease Control and Prevention on Monday updated its Covid vaccine guidance to recommend Covid shots for people 65 and older and only after they consult a doctor or pharmacist. A press ...

Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a rare clotting disorder that emerged in a small number of people who received ...

Scientists say they now know what went wrong with Johnson & Johnson’s Covid vaccine - Some people who took the shots developed a rare and severe type of blood clot called VITT ...